Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and earnings. The company's top line has been growing at a good clip in recent ...

Power was restored Sunday morning to the bulk of the 130,000 homes and businesses in San Francisco impacted by a massive outage a day earlier that caused major disruptions in the city. About 17,000 ...

In today’s newsletter, Paul Veradittakit, managing partner at Pantera Capital, shares his 2026 predictions on crypto, real-world asset tokenization and AI. Programming Note: This will be our last ...

Spotify Technology SA will begin testing a new feature that allows users to type an idea for a playlist into the app and receive a unique set of songs based on their historical taste and behavior. The ...

The demand for energy is increasing rapidly, driven by the growth of data centers and the electrification of the power grid. Natural gas is a top energy source due to its cleaner-burning ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Grandfather, 3-month-old granddaughter dead after violent dog attack Opinion: Why Marjorie ...

Ramesh Agarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

We know this has been a strange NFL season, but the fact that the Kansas City Chiefs might miss the playoffs only solidifies it. Unless the Chiefs win out -- which Patrick Mahomes essentially said ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...